RXi Pharmaceuticals Corporation (NASDAQ:RXII)

CAPS Rating: 2 out of 5

Recs

0
Player Avatar anchor68 (76.24) Submitted: 1/9/2013 9:00:20 PM : Outperform Start Price: $1.86 RXII Score: +23.43

This stock wouldn't have gotten Teva Pharmaceuticals interested if the results weren't solid. I can't imagine this stock being lower than $2 for long. Great entry point right now!

Featured Broker Partners


Advertisement